Investigations of B cell phenotype and metabolic function in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Mensah, 2019 (PhD)

Dated from April 2019, but I don't think this has been posted before.

I had thought most B-cell related work would've ended with the Rituximab trial failure, but apparently not:

https://discovery.ucl.ac.uk/id/eprint/10080812/20/Mensah_10080812_thesis_redacted.pdf

Just starting to work my way through, but very interesting indeed.

 

The work was set up as a prelude to a potential further phase 2 trial in the UK about 5 years ago. It takes time for PhD projects to come to completion.

 

Yep, my fault. (I was brain-foggily thinking that the RTX trial was from a decade ago and so this must've been more novel - mixing the timeline up with XMRV).